Dustin Costescu

ORCID: 0000-0003-3841-536X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Reproductive Health and Contraception
  • Maternal and fetal healthcare
  • Maternal and Perinatal Health Interventions
  • Ectopic Pregnancy Diagnosis and Management
  • Reproductive Health and Technologies
  • Global Maternal and Child Health
  • Prenatal Substance Exposure Effects
  • Cervical Cancer and HPV Research
  • Homelessness and Social Issues
  • Criminal Justice and Corrections Analysis
  • Pregnancy and Medication Impact
  • Meta-analysis and systematic reviews
  • Simulation-Based Education in Healthcare
  • Homicide, Infanticide, and Child Abuse
  • Gynecological conditions and treatments
  • Urological Disorders and Treatments
  • Sexual function and dysfunction studies
  • Neuroendocrine regulation and behavior
  • LGBTQ Health, Identity, and Policy
  • Diversity and Career in Medicine
  • Maternal Mental Health During Pregnancy and Postpartum
  • Primary Care and Health Outcomes
  • Poisoning and overdose treatments
  • Menstrual Health and Disorders
  • Intimate Partner and Family Violence

McMaster University
2013-2023

Hamilton Health Sciences
2016-2022

University of Ottawa
2022

Booz Allen Hamilton (United States)
2016

Queen's University
2013

10.1016/j.jogc.2017.12.010 article EN Journal of Obstetrics and Gynaecology Canada 2018-06-01

Hormonal fluctuations associated with female reproductive life events may precipitate or worsen affective episodes in women bipolar disorder (BD). Previous studies have shown that BD report higher rates of premenstrual dysphoric (PMDD) than controls. Further, who worsening mood display a worse course their illness. Despite this, the neural correlates comorbid and PMDD not been investigated.Eighty-five [CTRL, n = 25; PMDD, 20; BD, 21; (BDPMDD), 19], regularly cycling women, on hormonal...

10.3389/fpsyt.2017.00301 article EN cc-by Frontiers in Psychiatry 2018-01-10

<h3>Importance</h3> Women who experience imprisonment have high morbidity and an increased risk of adverse pregnancy outcomes. Antenatal care could modify pregnancy-related risks, but there is a lack evidence regarding antenatal in this population. <h3>Objectives</h3> To examine quality indicators for women to compare these data with the general <h3>Design, Setting, Participants</h3> This population-based, retrospective cohort study used linked correctional health administrative from...

10.1001/jamanetworkopen.2020.12576 article EN cc-by-nc-nd JAMA Network Open 2020-08-06

10.1016/s1701-2163(15)30811-2 article FR Journal of Obstetrics and Gynaecology Canada 2013-10-01

OBJECTIVE: To assess the relationship of adherence and pregnancy in participants using an estetrol drospirenone combined oral contraceptive. METHODS: We performed a secondary analysis for which we pooled data from two parallel, multicenter, phase 3 trials (United States Canada, Europe Russia) that enrolled 16–50 years age to receive 15 mg 24 hormone four placebo pills regimen up 13 cycles. Participants reported pill intake, sexual intercourse, other contraceptive use on paper diaries....

10.1097/aog.0000000000005155 article EN Obstetrics and Gynecology 2023-04-06

10.1016/j.jogc.2017.05.034 article EN Journal of Obstetrics and Gynaecology Canada 2017-09-02

CINtec PLUS and cobas HPV tests were assessed for triaging women referred to colposcopy with a history of LSIL cytology. Both performed at baseline using ThinPrep cervical specimens biopsy confirmed intraepithelial neoplasia grade 2 or worse (CIN2+) served as the clinical endpoint.In all ages, (19-76 years, n = 600), 44.3% (266/600) tested positive vs. 55.2% (331/600) (p 0.000). Based on 224 having biopsies, sensitivity detect CIN2+ (n 54) was 81.5% (44/54) 94.4% (51/54) testing 0.039);...

10.1016/j.pvr.2020.100206 article EN cc-by-nc-nd Papillomavirus Research 2020-08-20

CINtec PLUS and cobas HPV tests were compared for triaging patients referred to colposcopy with a history of LSIL cytology in 2-year prospective study. Cervical specimens tested once at enrollment, test positivity rates determined. Test performance was ascertained cervical intraepithelial neoplasia grade 2 or worse (CIN2+) CIN3 (CIN3+) serving as clinical endpoints.In all ages, (19-76 years, n= 598), 44.3% positive vs. 55.4% (p< 0.001). To detect CIN2+ (n= 99), 81.8% sensitive 93.9% testing...

10.3233/cbm-210366 article EN other-oa Cancer Biomarkers 2022-01-04
Coming Soon ...